Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
Jan 1, 2013
By:
Angie Drakulich
Our editorial advisory board members provide their perspective on what's ahead in the biopharmaceutical industry.
|
FDA talks about the changing scope of regulatory science.
Jan 1, 2013
By:
Angie Drakulich
FDA talks about the changing scope of regulatory science.
|
A recent ISPE guidance provides a baseline for the design of quality laboratory facilities.
Jan 1, 2013
By:
Angie Drakulich
A recent ISPE guidance provides a baseline for the design of quality laboratory facilities.
|
Keeping tabs on crucial medicines should be part of consumers' and manufacturers' emergency-preparedness plans.
Dec 1, 2012
By:
Angie Drakulich
Keeping tabs on crucial medicines should be part of consumers' and manufacturers' emergency-preparedness plans.
|
Global coordination tactics that incorporate online technologies and social media are reshaping disease prevention and response.
Nov 1, 2012
By:
Angie Drakulich
Global coordination tactics that incorporate online technologies and social media are reshaping disease prevention and response.
|
NECC gets 483 after fungal meningitis outbreak.
Oct 29, 2012
By:
Angie Drakulich
NECC gets 483 after fungal meningitis outbreak.
|
Oct 15, 2012
By:
Angie Drakulich
At this week's AAPS 2012 Annual Meeting in Chicago, graduate students across the country are being honored for their research and work in bio/pharmaceutical innovation. BioPharm International had the chance to talk with a few of the recipients.
|
Will the next US President support the backbone of our industry?
Oct 1, 2012
By:
Angie Drakulich
Will the next US President support the backbone of our industry?
|
Although FDA cannot do anything to stop drugs from being discontinued, it can do something about supply and quality problems that lead to shortages.
Jul 1, 2012
By:
Angie Drakulich
Although FDA cannot do anything to stop drugs from being discontinued, it can do something about supply and quality problems that lead to shortages.
|
|
